Prediabetes, Malignant Left Ventricular Hypertrophy, and Risk of Incident Heart Failure Among Hypertensive Adults

Arnaud D Kaze1, Stephen P Juraschek2, Jordana B Cohen3

  • 1Division of Cardiology, Department of Medicine, Banner-University Medical Center Phoenix, The University of Arizona College of Medicine-Phoenix, Arizona, USA.

JACC. Advances
|August 5, 2026
PubMed

Insights

Prediabetes combined with malignant left ventricular hypertrophy (LVH) significantly increases heart failure (HF) risk in hypertensive adults. This combination, not prediabetes alone, identifies a high-risk group for targeted prevention.

Area of Science:

  • Cardiology
  • Endocrinology
  • Preventive Medicine

Background:

  • Prediabetes is prevalent in hypertensive individuals, but its independent impact on heart failure (HF) risk, especially with subclinical cardiac abnormalities, is not fully understood.
  • Hypertension and prediabetes are significant risk factors for cardiovascular disease, necessitating a deeper understanding of their combined effects on HF development.

Purpose of the Study:

  • To investigate the association between prediabetes, malignant left ventricular hypertrophy (LVH), and incident heart failure (HF) risk.
  • To determine if prediabetes exacerbates HF risk in hypertensive adults with LVH, defined by subclinical myocardial injury or stress.

Main Methods:

  • Prospective cohort analysis of 8,131 hypertensive adults without diabetes from the SPRINT trial.
  • Left ventricular hypertrophy (LVH) assessed via Cornell voltage product; subclinical myocardial injury by troponin I levels; subclinical myocardial stress by NT-proBNP levels.
  • Cox proportional hazards models used to calculate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for HF events.

Main Results:

  • A total of 115 HF events occurred during a median follow-up of 3.3 years.
  • Hypertensive adults with both prediabetes and malignant LVH exhibited a 3.55-fold increased risk of HF compared to normoglycemic individuals without malignant LVH.
  • Prediabetes combined with LVH and myocardial injury or stress showed HRs of 4.02 and 4.04, respectively; prediabetes alone did not significantly increase HF risk (HR: 1.24).

Conclusions:

  • The coexistence of prediabetes and malignant LVH identifies a high-risk subgroup for heart failure among hypertensive adults.
  • Integrating glycemic status, ECG-derived LVH, and cardiac biomarkers can improve HF risk stratification and guide preventive interventions.
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...